Vasorelaxant effects of β-phenylethylamine in rat aorta involve a combination of α1-adrenergic receptor antagonism and endothelium-mediated NO release

Raw data of the study entitled "Vasorelaxant effects of β-phenylethylamine in rat aorta involve a combination of α1-adrenergic receptor antagonism and endothelium-mediated NO release"

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-13
DOI
https://doi.org/10.5281/zenodo.14150330
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vasorelaxant effects of β-phenylethylamine in rat aorta involve a combination of α1-adrenergic receptor antagonism and endothelium-mediated NO release

Zenodo (CERN European Organization for Nuclear Research)
Pharmacology and Obesity Treatment
article

Vasorelaxant effects of β-phenylethylamine in rat aorta involve a combination of α1-adrenergic receptor antagonism and endothelium-mediated NO release

article en

Abstract

Raw data of the study entitled "Vasorelaxant effects of β-phenylethylamine in rat aorta involve a combination of α1-adrenergic receptor antagonism and endothelium-mediated NO release"

Zenodo (CERN European Organization for Nuclear Research)
Universidade Federal do Ceará (BR), Universidade Federal Rural do Semi-Árido (BR)
Openalex Percentile: Top 69%
Pharmacology and Obesity Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Vasorelaxant effects of β-phenylethylamine in rat aorta involve a combination of α1-adrenergic receptor antagonism and endothelium-mediated NO release · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS